Discover Try Use Study with Adopt ScreenCell
Innovative Liquid Biopsy Technology For Rapid and Efficient Isolation of CTCs
ScreenCell: your
go-to partner
for liquid biopsy solutions
ScreenCell is reshaping liquid biopsy and modern oncology as a pioneer in capturing circulating tumor cells (CTCs) with its performant and cost-effective filtration devices.
Because numbers
speak louder than words
Scientific articles
Explore over 70 scientific articles authored by our customers and partners that showcase the effectiveness of our technology
Global Reach
Over 70,000 filtration units used in fundamental and clinical research projects worldwide.
Proven Tenure
Trace back over 10 years of experience, know-how and innovation.
A technology made for liquid biopsy
+90%
circulating tumor cells recovery rate.
Through its innovative filtration devices, CYTO and MB, ScreenCell has transformed the isolation and enrichment of circulating tumor cells (CTCs) in liquid biopsy, delivering an unparalleled blend of simplicity, precision, and efficiency.
Discover ScreenCell kits
Explore the full range of ScreenCell kits, each specifically designed to meet the diverse needs of liquid biopsy applications.
FCD
Blood sample
< 3 days
or
Cells fixed detached
from the isolation support for analysis in suspension or on slide
FCD-SP
Blood sample
< 4 hours
or
Cells fixed detached
from the isolation support for analysis in suspension or on slide
LCD
Blood sample
< 4 hours
Living cells detached
from the isolation support for suspension analysis
A range of applications
at your disposal
ScreenCell customized services
Training and technology transfer
Distant analyses of your samples
Adapted protocols
Customer support
Training and technology transfer
Distant analyses of your samples
Adapted protocols
Customer support
Our lastest news
enhancing patient care
through reliable CTC analysis